Delcath Systems Inc logo

Delcath Systems Inc

$ 3.33 +0.06 (+1.83%) 10:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 28.63M
Enterprise V:
$ 34.34M
Volume:
6.85K
Avg Vol (2M):
18.37K
Also Trade In:
Volume:
6.85K
Market Cap $:
28.63M
PE Ratio:
At Loss
Avg Vol (2-Month):
18.37K
Enterprise Value $:
34.34M
PB Ratio:
0
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
Name Current Vs Industry Vs History
Cash-To-Debt 0.62
Equity-to-Asset -0.14
Debt-to-Equity -5.77
Debt-to-EBITDA -0.59
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -32.26
Distress
Grey
Safe
Beneish M-Score -3.45
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 52.27
9-Day RSI 40.08
14-Day RSI 37.36
6-1 Month Momentum % -35.57
12-1 Month Momentum % -55.95

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.57
Quick Ratio 1.4
Cash Ratio 0.83
Days Inventory 1014.57
Days Sales Outstanding 15.42
Days Payable 814.4

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -712.9
Name Current Vs Industry Vs History
Gross Margin % 85.02
Operating Margin % -732.72
Net Margin % -797.16
ROE % -367.96
ROA % -107.68
ROIC % -461.15
ROC (Joel Greenblatt) % -680.31
ROCE % -135.68

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 6.89
EV-to-EBIT -1.25
EV-to-EBITDA -1.25
EV-to-Revenue 9.14
EV-to-Forward-Revenue 3.37
EV-to-FCF -1.46
Earnings Yield (Greenblatt) % -80.17

Financials (Next Earnings Date:2022-11-09 Est.)

DCTH's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:DCTH

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 3.805
EPS (TTM) ($) -3.81
Beta 1.15
Volatility % 37.09
14-Day RSI 37.36
14-Day ATR ($) 0.220316
20-Day SMA ($) 3.6195
12-1 Month Momentum % -55.95
52-Week Range ($) 2.9782 - 11.9517
Shares Outstanding (Mil) 8.6

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Delcath Systems Inc Filings

Document Form Filing Date
No Filing Data

Delcath Systems Inc Analysis

Share your research

Headlines

See More
No news.